tiprankstipranks
CKD Bio Corp. (KR:063160)
:063160
South Korea Market
063160
CKD Bio Corp.
RESEARCH TOOLSreports

CKD Bio Corp. (063160) Financial Statements

― Followers

CKD Bio Corp. Financial Overview

CKD Bio Corp.'s market cap is currently ₩72.85B. The company's EPS TTM is $-1957.79; its P/E ratio is -6.68; and it has a dividend yield of 0.46%. CKD Bio Corp. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 160.07B₩ 171.76B₩ 160.35B₩ 156.04B₩ 142.24B
Gross Profit₩ 26.10B₩ 35.94B₩ 5.01B₩ 16.79B₩ 13.31B
Operating Income₩ 3.61B₩ 10.95B₩ -20.15B₩ -14.77B₩ -9.81B
EBITDA₩ 19.26B₩ 31.17B₩ -1.63B₩ 2.29B₩ 5.56B
Net Income₩ -2.89B₩ 8.70B₩ -24.19B₩ -16.70B₩ -6.58B
Balance Sheet
Cash & Short-Term Investments₩ 1.50B₩ 1.16B₩ 3.70B₩ 12.72B₩ 3.53B
Total Assets₩ 299.87B₩ 284.49B₩ 293.79B₩ 312.59B₩ 298.54B
Total Debt₩ 144.96B₩ 131.21B₩ 146.93B₩ 138.93B₩ 109.38B
Net Debt₩ 143.53B₩ 130.11B₩ 143.30B₩ 134.27B₩ 105.91B
Total Liabilities₩ 172.83B₩ 153.48B₩ 170.76B₩ 164.79B₩ 137.05B
Stockholders' Equity₩ 127.04B₩ 131.01B₩ 123.02B₩ 147.80B₩ 161.49B
Cash Flow
Free Cash Flow₩ -10.95B₩ 9.75B₩ -18.00B₩ -10.43B₩ -26.59B
Operating Cash Flow₩ -4.14B₩ 14.03B₩ -7.22B₩ -3.20B₩ -5.88B
Investing Cash Flow₩ -6.96B₩ -4.75B₩ -1.20B₩ -20.55B₩ -20.39B
Financing Cash Flow₩ 11.45B₩ -11.81B₩ 7.40B₩ 24.96B₩ 28.27B
Currency in KRW

CKD Bio Corp. Earnings and Revenue History

Income Statement >

CKD Bio Corp. Debt to Assets

Balance Sheet >

CKD Bio Corp. Cash Flow

Cash Flow >

CKD Bio Corp. Forecast EPS vs Actual EPS

Earnings >